Memphasys LtdASX: MEM

Felix Clinical Trial complete, Data Lock expected in 2 weeks

· Issued by Memphasys Ltd

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Memphasys Ltd has announced the completion of the final patient visit in its Felix clinical trial, with data lock expected soon. The company is currently focused on data clean-up and verification to ensure the accuracy of the trial results before statistical analysis. Preliminary results are anticipated to be released in early March, which will support the CE Mark submission for market entry in Europe. This milestone is crucial for advancing regulatory approvals in other regions, including Australia and India.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Memphasys Ltd on 6ix

Story so far

Earlier from Memphasys

Later from Memphasys

All Memphasys news releases